Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Certificate of Incorporation of Felicitex Therapeutics Inc
- 3.2 Amended and Restated Certificate of Incorporation of Felicitex Therapeutics Inc
- 3.3 Second Amended and Restated Certificate of Incorporation of Felicitex Therapeutics Inc
- 3.4 Certificate of Amendment of Felicitex Therapeutics Inc
- 3.5 Second Certificate of Amendment of Felicitex Therapeutics Inc
- 3.6 Third Amended and Restated Certificate of Incorporation of Felicitex Therapeutics Inc
- 3.8 Bylaws of Felicitex Therapeutics Inc
- 3.9 Certificate of Merger of Tarmeta Biosciences, LLC and Felicitex Therapeutics Inc., Dated December 30, 2021
- 4.5 Warrant to Purchase Common Shares Between Felicitex Therapeutics Inc. and Marc Duey, Dated March 17, 2020
- 4.6 Warrant to Purchase Common Shares Between Felicitex Therapeutics Inc. and Marc Duey, Dated March 17, 2021
- 4.7 Warrant to Purchase Common Shares Between Felicitex Therapeutics, Inc and Marc Duey, Dated November 2, 2021
- 10.1 Agreement and Plan of Merger Between Felicitex Therapeutics Inc. and Tarmeta Biosciences, LLC, Dated December 30, 2021
- 10.2 License and Collaboration Agreement Between Felicitex Therapeutics Inc. and Diaxonhit, Dated April 16, 2014
- 10.3 Amendment No. 1 to License and Collaboration Agreement Between Felicitex Therapeutics Inc. and Diaxonhit, Dated July 21, 2014
- 10.4 Amendment No. 2 to License and Collaboration Agreement Between Felicitex Therapeutics Inc. and Eurobio Scientific Sa (Formerly Diaxonhit), Dated February 14, 2022
- 10.5 Research Collaboration and Licensing Option Agreement Between Felicitex Therapeutics Inc. and Selvita S.a., Dated November 6, 2014
- 10.6 Notice of Option Exercise Under the Research Collaboration and Option Agreement Dated October 1, 2014, Dated August 30, 2018
- 10.7 Exclusive License Agreement Between Felicitex Therapeutics Inc. and Selvita S.a., Dated December 31, 2018
- 10.8 Amendment No. 1 to Exclusive Licensing Agreement Between Felicitex Therapeutics Inc. and Selvita S.a., Dated April 16, 2019
- 10.9 Material Transfer and Royalty Agreement Between Felicitex Therapeutics Inc. and Memorial Sloan Kettering Cancer Center, Dated December 4, 2020
- 10.10 Material Transfer Agreement Between Felicitex Therapeutics Inc. and Equilibre Biopharmaceuticals, Dated February 15, 2021
- 10.11 Material Transfer Agreement Between Felicitex Therapeutics Inc. and Whitehead Institute for Biomedical Research, Dated January 29, 2020
- 10.12 Employment Agreement Between Felicitex Therapeutics Inc. and Maria Vilenchik Dated March 10, 2022
- 10.13 Employment Contract Between Felicitex Therapeutics and Alexei Belenky Dated December 30, 2021
- 10.14 Form of Independent Director Agreement Between Felicitex Therapeutics Inc. and Each Independent Director and Each Director Nominee
- 10.15 Form of Indemnification Agreement Between Felicitex Therapeutics Inc. and Each Independent Director and Each Director Nominee
- 10.16 Felicitex Therapeutics Inc. 2012 Stock Option and Restricted Stock Plan
- 10.17 Felicitex Therapeutics Non-statutory Stock Option Agreement with Valeria Povolotsky, Dated March 1, 2013
- 10.18 Felicitex Therapeutics Non-statutory Stock Option Agreement with Yuriy Gankin Dated March 1, 2013
- 10.19 Felicitex Therapeutics Non-statutory Stock Option Agreement with Michael Frid Dated March 1, 2013
- 10.20 Felicitex Therapeutics Non-statutory Stock Option Agreement with Maria Vilenchik Dated March 1, 2013
- 10.21 Felicitex Therapeutics Inc. 2022 Equity Incentive Plan
- 10.22 Shareholder Loan Agreement Between Marc Duey and Felicitex Therapeutics Inc., Dated January 16, 2018
- 10.23 Shareholder Loan Agreement Between Marc Duey and Felicitex Therapeutics Inc., Dated March 31, 2020
- 10.24 Grid Note Between Marc Duey and Felicitex Therapeutics Dated March 16, 2022
- 10.25 Grant Agreement from Massachusetts Life Sciences Center Dated July 15, 2015
- 10.26 Consulting Agreement Between Felicitex Therapeutics Inc. and Michael Frid, Dated July 20, 2012
- 10.27 Consulting Agreement Between Felicitex Therapeutics Inc. and Valeria Povolotsky, PH.D., Dated July 20, 2012
- 10.28 Lease Between Felicitex Therapeutics Inc., Tarmeta Biosciences, LLC and Kaufman Nir LLC, Dated March 15, 2017
- 10.30 Board of Directors Agreement Between Felicitex Therapeutics Inc. and Yuriy Gankin, Dated July 23, 2021
- 10.31 Board of Directors Agreement Between Felicitex Therapeutics Inc. and Valeria Povolotsky, Dated July 23, 2021
- 10.32 Board of Directors Agreement Between Felicitex Therapeutics Inc. and Michael Frid, Dated July 23, 2021
- 10.33 Board of Directors Agreement Between Felicitex Therapeutics Inc. and Alex Shlyankevich, Dated July 23, 2021
- 10.34 Board of Directors Agreement Between Felicitex Therapeutics Inc. and Marc Duey, Dated July 23, 2021
- 10.35 Board of Directors Agreement Between Felicitex Therapeutics Inc. and Maria Vilenchik, Dated July 23, 2021
- 10.36 Material Transfer and Agreement Between Felicitex Therapeutics Inc. and Uab Dolcerx Baltika, Dated May 15, 2021
- 10.37 Material Transfer and Agreement Between Felicitex Therapeutics Inc. and Barbara Ann Karmanos Cancer Institute, Dated July 18, 2022
- 14.1 Code of Ethics and Business Conduct
- 21.1 List of Subsidiaries
- 23.1 Consent of Friedman LLP
- 99.1 Audit Committee Charter
- 99.2 Compensation Committee Charter
- 99.3 Nominating and Corporate Governance Committee Charter
- 99.5 Consent of Douglas T. Moore to Be Named As a Director Nominee
- EX-FILING FEES Filing Fees Table
Associated filings
FLCT similar filings
Filing view
External links
Exhibit 10.20